FDA clears way on drug for children with ADHD

09/3/2009 | Reuters

The Food and Drug Administration has approved an extended-release drug to treat attention-deficit/hyperactivity disorder in children ages 6 to 17. Intuniv, created by the British company Shire, is expected to be available in the U.S. in November.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
School Improvement Officer
Kent School District
Kent, WA
Account Executive - Central Region
NWEA
Multiple Locations, SL_Multiple Locations
Account Manager
NWEA
Multiple Locations, SL_Multiple Locations
School Reading Coaches
Rowland Reading Foundation
Multiple Locations, SL_Multiple Locations
Elementary School Principal
Kent School District
Kent, WA